Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Both NOD2 (CARD15) alleles are mutated in roughly 15% of patients with Crohn's disease, but functional effects are unclear. We analysed the cytokine response of peripheral blood mononuclear cells to muramyl dipeptide (MDP), the ligand for NOD2. MDP induced little TNFalpha or interleukin 1beta, but strong interleukin-8 secretion. MDP also substantially upregulated secretion of TNFalpha and interleukin 1beta induced by toll-like receptor ligands. These effects were abolished by the most common Crohn's NOD2 double mutant genotypes at low nanomolar MDP concentrations, and provide the basis to develop a test of NOD2 functional deficiency. In Crohn's disease, there are defects in neutrophil recruitment driven by NOD2 and interleukin 8 and in cross talk between the NOD2 and toll-like receptor pathways, which suggests that the immune system fails to receive an early priming signal.

Original publication




Journal article



Publication Date





1794 - 1796


Acetylmuramyl-Alanyl-Isoglutamine, Crohn Disease, Genotype, Humans, Immunity, Innate, In Vitro Techniques, Interleukin-1, Interleukin-8, Intracellular Signaling Peptides and Proteins, Leukocytes, Mononuclear, Membrane Glycoproteins, Mutation, Nod2 Signaling Adaptor Protein, Receptor Cross-Talk, Receptors, Cell Surface, Signal Transduction, Toll-Like Receptors, Tumor Necrosis Factor-alpha, Up-Regulation